Hypothalamic-pituitary-thyroid axis function in women with a menstrually related mood disorder: Association with histories of sexual abuse

Psychosomatic Medicine

Volumn 74, Issue 8, 2012, Pages 810-816

  Bunevicius, Adomas ^a   Leserman, Jane ^a   Girdler, Susan S ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

menstrually related mood disorders; sexual abuse; thyroid hormones

Indexed keywords

LIOTHYRONINE; THYROTROPIN; THYROXINE;

ALCOHOL ABUSE; ANXIETY; ARTICLE; CORRELATION ANALYSIS; DEPRESSION; HORMONE BLOOD LEVEL; HYPOPHYSIS THYROID SYSTEM; HYPOTHALAMUS HYPOPHYSIS THYROID SYSTEM; MEDICAL HISTORY; MENSTRUALLY RELATED MOOD DISORDER; MOOD DISORDER; POSTTRAUMATIC STRESS DISORDER; PREMENSTRUAL SYNDROME; PRIORITY JOURNAL; SEXUAL ABUSE; SUBSTANCE ABUSE;

EID: 84867250465     PISSN: 00333174     EISSN: 15347796     Source Type: Journal    
DOI: 10.1097/PSY.0b013e31826c3397     Document Type: Article

References (48)

1. Bauer M, Goetz T, Glenn T, Whybrow PC. The thyroid-brain interaction in thyroid disorders and mood disorders. J Neuroendocrinol 2008;20: 1101-14.
2. Bunevicius R. Thyroid disorders in mental patients. Curr Opin Psychiatry 2009;22:391-5.
3. Wang S. Traumatic stress and thyroid function. Child Abuse Negl 2006; 30:585-8.
4. Mason JW. A review of psychoendocrine research on the pituitary thyroid system. Psychosom Med 1968;30:666-81.
5. Mason J, Southwick S, Yehuda R, Wang S, Riney S, Bremner D, Johnson D, Lubin H, Blake D, Zhou G, Gusman F, Charney D. Elevation of serum free triiodothyronine, total triiodothyronine, thyroxine-binding globulin, and total thyroxine levels in combat-related posttraumatic stress disorder. Arch Gen Psychiatry 1994;51:629-41.
6. Wang S, Mason J. Elevations of serum T3 levels and their association with symptoms in World War II veterans with combat-related posttraumatic stress disorder: replication of findings in Vietnam combat veterans. Psychosom Med 1999;61:131-8.
7. Kozari(-Kovaci( D, Karlovi( D, Kocijan-Hercigonja D. Elevation of serum total triiodothironine and free triiodothironine in Croatian veterans with combat-related post-traumatic stress disorder. Mil Med 2002;167:846-9.
8. Wang S, Mason J, Southwick S, Johnson D, Lubin H, Charney D. Relationships between thyroid hormones and symptoms in combat-related posttraumatic stress disorder. Psychosom Med 1995;57:398-402.
9. Plichta SB, Falik M. Prevalence of violence and its implications for women's health. Womens Health Issues 2001;11:244-58.
10. Friedman MJ, Wang S, Jalowiec JE, McHugo GJ, McDonagh-Coyle A. Thyroid hormone alterations among women with posttraumatic stress disorder due to childhood sexual abuse. Biol Psychiatry 2005;57:1186-92.
11. Pilver CE, Levy BR, Libby DJ, Desai RA. Posttraumatic stress disorder and trauma characteristics are correlates of premenstrual dysphoric disorder. Arch Women Ment Health 2011;14:383-93.
12. Golding JM, Taylor DL, Menard L, King MJ. Prevalence of sexual abuse history in a sample of women seeking treatment for premenstrual syndrome. J Psychosom Obstet Gynaecol 2000;21:69-80.
13. Girdler SS, Sherwood A, Hinderliter AL, Leserman J, Costello NL, Straneva PA, Pedersen CA, Light KC. Biological correlates of abuse in women with premenstrual dysphoric disorder and healthy controls. Psychosom Med 2003;65:849-56.
14. Gehlert S, Song IH, Chang CH, Hartlage SA. The prevalence of premenstrual dysphoric disorder in a randomly selected group of urban and rural women. Psychol Med 2009;39:129-36.
15. Biggs WS, Demuth RH. Premenstrual syndrome and premenstrual dysphoric disorder. Am Fam Physician 2011;84:918-24
16. Halbreich U, Borenstein J, Pearlstein T, Kahn LS. The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS/PMDD). Psychoneuroendocrinology 2003;28(suppl 3):1-23.
17. Cunningham J, Yonkers KA, O'Brien S, Eriksson E. Update on research and treatment of premenstrual dysphoric disorder. Harv Rev Psychiatry 2009;17:120-37.
18. Brayshaw ND, Brayshaw DD. Thyroid hypofunction in premenstrual syndrome. N Engl J Med 1986;315:1486-7.
19. Girdler SS, Pedersen CA, Light KC. Thyroid axis function during the menstrual cycle in women with premenstrual syndrome. Psychoneuroendocrinology 1995;20:395-403.
20. Roy-Byrne PP, Rubinow DR, Hoban MC, Grover GN, Blank D. TSH and prolactin responses to TRH in patients with premenstrual syndrome. Am J Psychiatry 1987;144:480-4.
21. Schmidt PJ, Grover GN, Roy-Byrne PP, Rubinow DR. Thyroid function in women with premenstrual syndrome. J Clin Endocrinol Metab 1993; 76:671-4.
22. Girdler SS, Thompson KS, Light KC, Leserman J, Pedersen CA, Prange AJ Jr. Historical sexual abuse and current thyroid axis profiles in women with premenstrual dysphoric disorder. Psychosom Med 2004;66:403-10.
23. Leserman J. Sexual abuse history: prevalence, health effects, mediators, and psychological treatment. Psychosom Med 2005;67:906-15.
24. Gutman DA, Nemeroff CB. Persistent central nervous system effects of an adverse early environment: clinical and preclinical studies. Physiol Behav 2003;79:471-8.
25. Penza KM, Heim C, Nemeroff CB. Neurobiological effects of childhood abuse: implications for the pathophysiology of depression and anxiety. Arch Women Ment Health 2003;6:15-22.
26. Girdler SS, Leserman J, Bunevicius R, Klatzkin R, Pedersen CA, Light KC. Persistent alterations in biological profiles in women with abuse histories: influence of premenstrual dysphoric disorder. Health Psychol 2007;26:201-13.
27. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed., text rev.Washington, DC: American Psychiatric Association; 2000.
28. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998;59:22-33.
29. Leserman J, Drossman DA, Li Z, Toomey TC, Nachman G, Glogau L. Sexual and physical abuse history in gastroenterology practice: how types of abuse impact health status. Psychosom Med 1996;58:4-15.
30. Endicott J, Nee J, Harrison W. Daily record of severity of problems (DRSP): reliability and validity. Arch Women Ment Health 2006;9:41-9.
31. Rubinow DR, Roy-Byrne PP, Hoban MC, Gold PW, Post RM. Prospective assessment of menstrually related mood disorders. Am J Psychiatry 1984; 141:684-6.
32. Girdler SS, Pedersen CA, Straneva PA, Leserman J, Stanwyck CL, BenJ Amin S, Light KC. Dysregulation of cardiovascular and neuroendocrine responses to stress in premenstrual dysphoric disorder. Psychiatry Res 1998; 81:163-78.
33. Weissman MM, Olfson M. Depression in women: implications for health care research. Science 1995;269:799-801.
34. Blake F, Salkovskis P, Gath D, Day A, Garrod A. Cognitive therapy for premenstrual syndrome: a controlled trial. J Psychosom Res 1998;45:307-18.
35. Nilsson OR, Melander A, Tegler L. Effects and plasma levels of propranolol and metoprolol in hyperthyroid patients. Eur J Clin Pharmacol 1980;18:315-20.
36. Yasuzawa-Amano S, Toyoda N, Maeda A, Kosaki A, Mori Y, Iwasaka T, Nishikawa M. Expression and regulation of type 2 iodothyronine deiodinase in rat aorta media. Endocrinology. 2004;145:5638-45.
37. Diegoli MS, da Fonseca AM, Diegoli CA, Pinotti JA. A double-blind trial of four medications to treat severe premenstrual syndrome. Int J Gynaecol Obstet 1998;62:63-7.
38. Shad MU, Suris AM, North CS. Novel combination strategy to optimize treatment for PTSD. Hum Psychopharmacol [electronic publication ahead of print]. doi: 10.1002/hup.1171.
39. Pitman RK, Sanders KM, Zusman RM, Healy AR, Cheema F, Lasko NB, Cahill L, Orr SP. Pilot study of secondary prevention of posttraumatic stress disorder with propranolol. Biol Psychiatry 2002;51:189-92.
40. Bunevicius R, Hinderliter AL, Light KC, Leserman J, Pedersen CA, Girdler SS. Histories of sexual abuse are associated with differential effects of clonidine on autonomic function in women with premenstrual dysphoric disorder. Biol Psychol 2005;69:281-96.
41. Haviland MG, Sonne JL, Anderson DL, Nelson JC, Sheridan-Matney C, Nichols JG, Carlton EI, Murdoch WG. Thyroid hormone levels and psychological symptoms in sexually abused adolescent girls. Child Abuse Negl 2006;30:589-98.
42. De Bellis MD, Burke L, Trickett PK, Putnam FW. Antinuclear antibodies and thyroid function in sexually abused girls. J Trauma Stress 1996;9: 369-78.
43. Walsh K, Fortier MA, Dilillo D. Adult coping with childhood sexual abuse: a theoretical and empirical review. Aggress Violent Behav 2010;15:1-13.
44. Hollander CS, Mitsuma T, Shenkman L, Woolf P, Gershengorn MC. Thyrotropin-releasing hormone: evidence for thyroid response to intravenous injection in man. Science 1972;175:209-10.
45. Prange AJ Jr. Thyroid axis sustaining hypothesis of posttraumatic stress disorder. Psychosom Med 1999;61:139-40.
46. Mason GA, Bondy SC, Nemeroff CB, Walker CH, Prange AJ Jr. The effects of thyroid state on beta-adrenergic and serotonergic receptors in rat brain. Psychoneuroendocrinology 1987;12:261-70.
47. Wegman HL, Stetler C. A meta-analytic review of the effects of childhood abuse on medical outcomes in adulthood. Psychosom Med 2009;71: 805-12.
48. Chen LP, Murad MH, Paras ML, Colbenson KM, Sattler AL, Goranson EN, Elamin MB, Seime RJ, Shinozaki G, Prokop LJ, Zirakzadeh A. Sexual abuse and lifetime diagnosis of psychiatric disorders: systematic review and meta-analysis. Mayo Clin Proc 2010;85:618-29.